NMRA NASDAQ
Neumora Therapeutics, Inc. Common Stock
1W: -26.2%
1M: -63.8%
3M: -70.4%
YTD: -79.1%
1Y: -71.3%
$0.50
-0.05 (-9.11%)
Weekly Expected Move ±12.7%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-213M
Net Income
+15.6% YoY
$-181M
Free Cash Flow
+7.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-187.1%
ROA-121.9%
ROIC231.9%
Valuation
P/E-0.4
P/B2.1
EV/EBITDA-1.0
Leverage
Debt/Equity0.01
Current Ratio4.50
Interest Cov.-32.1x
Quality Scores
Piotroski F2/9
Altman Z-16.50
Beneish M0.00